13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
Latham & Watkins Advises on Navios Merger
Navios Maritime Holdings Inc. (the Company) (NYSE: NM) and N Logistics Holdings Corporation (NLHC), a company controlled by the Company’s…
Latham & Watkins Assists Bosch in Securing CFIUS Clearance
The Bosch Group, a leading global supplier of technology and services, received clearance from the Committee on Foreign Investment in…
Latham & Watkins Advises on Abivax IPO on the Nasdaq Global Market
Abivax SA (Euronext Paris: FR0012333284 – ABVX), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural…
Latham Advises UL Solutions Inc. on Inaugural Private Offering of Senior Notes
Latham & Watkins represented UL Solutions Inc., a global leader in applied safety science, in its inaugural private offering of…
Latham & Watkins Advises Arcutis Biotherapeutics on Pricing of US$100 Million Public Offering
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, has announced the…
Latham & Watkins Advises on Onex Partners’ Acquisition of Accredited
Onex Corporation (TSX: ONEX) has announced that Onex Partners V has agreed to acquire Accredited, the global program management business…
